Colgate-Palmolive Q4 profit beat estimates on growth in oral care, pet nutrition

Reuters
01/30
Colgate-Palmolive Q4 profit beat estimates on growth in oral care, pet nutrition

Overview

  • Oral care leader's Q4 net sales rose 5.8%, beating analyst expectations

  • Adjusted EPS for Q4 beat analyst expectations

  • GAAP EPS declined due to $794 mln impairment charges in skin health business

Outlook

  • Colgate-Palmolive expects 2026 net sales growth of 2% to 6%

  • Company anticipates organic sales growth of 1% to 4% in 2026

  • Colgate-Palmolive expects gross profit margin expansion in 2026

Result Drivers

  • ORAL CARE AND PET NUTRITION - Growth in oral care and pet nutrition drove Q4 sales, excluding private label impact

  • IMPAIRMENT CHARGES - $794 mln impairment charges in skin health business affected GAAP EPS

  • MARKET SHARE - Colgate maintained strong global market share in toothpaste and manual toothbrushes

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Sales

Beat

$5.23 bln

$5.12 bln (12 Analysts)

Q4 Adjusted EPS

Beat

$0.95

$0.91 (16 Analysts)

Q4 EPS

-$0.05

Press Release: ID:nBw7DrpyXa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10